| Clinical data | |
|---|---|
| Other names | 4-Methyl-2,5-dimethoxy-β-ethoxyphenethylamine; 2,5-Dimethoxy-β-ethoxy-4-methylphenethylamine; 2,5-Dimethoxy-4-methyl-β-ethoxyphenethylamine; β-Ethoxy-2C-D; β-EtO-2C-D |
| Routes of administration | Oral |
| Drug class | Psychoactive drug |
| ATC code |
|
| Pharmacokinetic data | |
| Duration of action | 10 hours |
| Identifiers | |
| |
| Chemical and physical data | |
| Formula | C13H21NO3 |
| Molar mass | 239.315 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
BOED, also known as 4-methyl-2,5-dimethoxy-β-ethoxyphenethylamine or as β-ethoxy-2C-D, is a psychoactive drug of the phenethylamine, 2C, and BOx families. It is the β-ethoxy derivative of 2C-D and homologue of BOD (β-methoxy-2C-D). The drug was briefly described by Alexander Shulgin in his 1991 book PiHKAL (Phenethylamines I Have Known and Loved). Its dose was said to be 70 to 75 mg orally and its duration was 10 hours. The drug was said to be about 3-fold less potent than BOD. Its effects included a highly intoxicated state, no visual effects, appetite suppression, and diuresis. The chemical synthesis of the drug was also briefly described. It is a controlled substance in Canada under phenethylamine blanket-ban language.
| Phenethylamines |
| ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amphetamines |
| ||||||||||||||||
| Phentermines |
| ||||||||||||||||
| Cathinones |
| ||||||||||||||||
| Phenylisobutylamines (and further-extended) |
| ||||||||||||||||
| Catecholamines (and close relatives) |
| ||||||||||||||||
| Cyclized phenethylamines |
| ||||||||||||||||
| Related compounds |
| ||||||||||||||||
This hallucinogen-related article is a stub. You can help Wikipedia by adding missing information. |